CHU de Caen - Hôpital Côte de Nacre

Caen 14033

0 studies enrolling now · 3 studies all time

What they study most

Advanced Solid Tumors, Atrial Fibrillation, Diffuse Large B-cell Lymphoma (DLBCL), Epitheliod Sarcoma (ES), Follicular Lymphoma (FL), Hemophilia A, Mesothelioma, Non-Hodgkin Lymphoma (NHL), Prevention of Stroke or Systemic Embolism, Renal Medullary Carcinoma, Synovial Sarcoma

Studies at this site

• A Study to Assess Long-term Safety of Tazemetostat in Adult Participants of All Ages With Any Disease Treated With Tazemetostat in a Previous Clinical Study — Completed
• A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke — Stopped early
• BAX 855 PK-guided Dosing — Completed